Grotesque profits in the time of COVID-19
Vaccine equity goes for a toss as US recommends booster shots, while Pfizer and Moderna revenues soar by billions of dollars
We know vaccines are the way out of COVID-19, but how are India’s numbers stacked
India is adding the most to the pandemic’s tally now; yet, the vaccination drive has lost steam before any significant gains
Lateral Thoughts: Healthy ageing was never so attractive
Accessing COVID-19 vaccine is logistically difficult for the old and sick
Vaccines to prevent antimicrobial resistance: Accelerate trials for priority candidates, says WHO
Over 60 vaccines against antibiotic-resistant pathogens in clinical development stage
How Rwanda is managing its COVID-19 vaccination rollout plans
It’s been over a year since COVID-19 was declared a pandemic. In an amazing feat of science and technology, a number of safe and effective …
COVID-19 vaccine update: People above 45 eligible for jabs from April 1
Ministry of Home Affairs releases updated guidelines for COVID-19 control
Pfizer withdraws application for Emergency Use Authorisation in India
The company will resubmit application after getting more data
COVID-19: What will be a fair policy to distribute vaccine
No country is safe if only its own citizens are inoculated; the question of equitable distribution of a vaccine is as much a global concern as it …
Wealthy nations starved the developing world of vaccines. Omicron shows the cost of this greed
10 high-income countries will be sitting on more than 870 million excess doses by end of 2021
COVID-19 vaccine: Oxford-AstraZeneca up to 90% effective in late stage trial
Adenovirus vaccine can be stored at 2-8°C; company to apply for emergency authorisation
COVID-19: Vaccine inequity persists as 2.8 billion people yet to receive even one dose
Low-income countries will also have to spend more to achieve 70% vaccination target
Vaccine hope
While Africa gets its first vaccine to fight malaria, India is still in the early stages of clinical trials
A granular look at UK’s COVID-19 ‘red list’ shows why it’s deeply flawed
Sudan is on the red list whereas South Sudan is not.
India is preparing for another COVID-19 surge but low vaccine coverage leaves it vulnerable
So far less than 10% of the population is fully vaccinated
Simply Put: COVID-19 vaccinate the hare, vaccinate the tortoise
COVID-19 vaccines: African countries get very few doses at very high prices
Guinea, one of the lowest-income countries, has received just 25 doses
Ghana first to approve Oxford’s malaria vaccine for children
Vaccine was up to 80% successful in clinical trials
In photos: Women leading poultry, livestock farming in rural Jharkhand
Poultry and livestock farming are a major source of income for those in rural Jharkhand, especially women, who are largely in charge of the …
Year(s) of the virus: Things we must not forget
The sheer power of the virus, our collective callousness, the sufferings of the working class... there are lessons to be learnt …
When will we reach herd immunity? Here are 3 reasons that’s a hard question to answer
It’s important to acknowledge it’s difficult to pin down a single magic number for herd immunity from COVID-19
WHO allows self-collected samples for HPV testing
The revised guidelines also suggested DNA-based tests for HPV infection is better than pap smear
Battling misinformation wars in Africa: Applying lessons from GMOs to COVID-19
Vaccine hesitancy was based mostly on perceptions about trust, importance, safety and efficacy, said a survey
Vaccine leadership, not chauvinism
We need the world’s drug regulators to come together to scrutinise clinical trial data — not take decisions one after another
Norway reports deaths related to COVID-19 vaccination
Situation not alarming, only ‘small exception’ affected by Pfizer mRNA vaccine: Medical director of Norwegian Medicines Agency
Iranian officials squabble over toll as COVID-19 sweeps West Asia
Meanwhile, Chinese federal government to increase funds to local governments even as world races to develop a vaccine